Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Developing a novel dengue vaccine 

Professor Arturo Reyes-Sandoval (Nuffield Department of Clinical Medicine) was awarded funding for his project to develop a new vaccine against dengue fever.

Modulating circadian rhythm disruption

Dr Sridhar Vasudevan (Department of Pharmacology) received funding to investigate a series of drugs which could be used to modulate and treat circadian rhythm disorders.

Developing slow-wave activity saturation as a marker of depth of anaesthesia 

Dr Katie Warnaby (Nuffield Department of Clinical Neurosciences) received funding to develop a new technique for measuring depth of anaesthesia in patients.


 

funded projects 2020

  • Endosomal escape technology to maximise the therapeutic potential of brain-targeted EVs conjugated with siRNA via GAPDH in Huntington's disease, Matthew Wood (Department of Paediatrics, Medical Sciences Division)
  • Neurostimulator with Artefact-free Recording of Electrophysiological Signals (NARES) for Closed-loop Stimulation, Huiling Tan (Medical Sciences Division)
  • Making Novel T cell Receptor Therapy for Acute Myeloid Leukaemia And Other Cancers, Paresh Vyas (Medical Sciences Division)
  • MAGNETO: Magnetic Actuators and Neural Engineering for TMS Optimisation, Timothy Denison (Mathematical, Physical & Life Sciences Division)
  • Application of an ultra-deep paired antibody sequencing platform for drug discovery in acute and persistent viral infections, John Frater (Medical Sciences Division)
  • Developing the anti-cancer therapeutic compound NBS037 to an IND filing and Phase I human trial, Karl J Morten (Medical Sciences Division)
  • Biased agonism of GPR84 as a novel dual anti-inflammatory and pro-repair mechanism, Angela Russell (Medical Sciences Division)
  • Circulating Placental DPPIV Positive Extracellular Vesicles as a Biomarker for Gestational Diabetes Mellitus, Manu Vatish (Medical Sciences Division)
  • Single-cell multi-omics as a technology platform for therapeutic target discovery in poor prognosis leukaemia, Adam Mead (Medical Sciences Division)
  • Oligonucleotide therapy for DMD cardiomyopathy via a patient derived cardiomyocyte screening platform, Matthew Wood (Medical Sciences Division)
  • Chimeric Bicyclic Peptides for Targeted Delivery of Antisense Oligonucleotides, Richard Raz (Medical Sciences Division)
  • The Fit for Labour test: risk stratification at the onset of labour to provide clinical decision-support to labour management, Antoniya Georgieva (Medical Sciences Division)
  • A Smart Infant Monitoring System (SIMS): A fully automated, real-time system that measures pain and can predict physiological instability following acute procedures in neonates, Aomesh Bhatt (Medical Sciences Division)
  • A novel pathway for therapeutic targeting in cardiometabolic diseases, Ellie Tzima (Radcliffe Department of Medicine, Medical Sciences Division)
  • Development of CRISPR gene therapy for Stargardt disease, Robert MacLaren (Medical Sciences Division)
  • AI-Based Covid-19 Diagnostic Tests using Routine Clinical Data, David Clifton (Mathematical, Physical & Life Sciences Division)
  • Translational development of an outer membrane vesicle vaccine against gonorrhoea, Christine Rollier (Medical Sciences Division)

View our previously funded projects